Teva may have new CEO on deck

Share this article:

Teva is rumored to be close to naming a new CEO, after a tumultuous few months that included the October announcement it was firing 10% of its staff, followed just weeks later with the public departure of then-CEO Jeremy Levin. Whether Levin was pushed or left on his own accord depends on the interviewee, but Eyal Deshesh has filled the role for the last several months.

Bloomberg reported Monday that board member Erez Vigodman is favored for the title, while BioCentury said Friday that Teva would not comment on whether the CEO of agrochemical firm Makhtshim Agan was in line for the job.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters